Logo
Website CRS  >  Search
Search
    Search for:
     

    Advanced search

    Rules:

    Only words with 2 or more characters are accepted
    Max 200 chars total
    Space is used to split words, "" can be used to search for a whole string (not indexed search then)
    AND, OR and NOT are prefix words, overruling the default operator
    +/|/- equals AND, OR and NOT as operators.
    All search words are converted to lowercase.

    Search for "individual"

    Displaying results 1 to 5 out of 5

      Services 81%
      ... Data Management (CDM), Medical Writing and Clinical Trial Supply Management (CTSM) support the clinical conduct according to the client’s individual needs. Over the past four decades, the group has performed more than 2.000 clinical trials, maintaining rigorous adherence to GCP-guidelines to ...
      Size: 29 K - Created: 18-11-12 - Modified: 07-10-19 14:36
    Path: /Services

      Medical Writing 74%
      ... documents – and this is where the Medical Writing Team of CRS comes in. The Medical Writing Team offers expert services ranging from preparing individual documents to producing all the documents needed for the draw up, coordination and documentation of clinical trials in a scientifically accurate ...
      Size: 31 K - Created: 18-11-12 - Modified: 02-08-19 10:27
    Path: /Services/Medical Writing

      Early Phase I to IIa 72%
      Early Phase I to IIa Each clinical trial brings new challenges and has to be seen from an individual perspective. The staff of CRS’s clinical pharmacological units (CPUs) dedicated itself to respond to these challenges for more than 40 years. ...
      Size: 32 K - Created: 18-11-12 - Modified: 07-10-19 14:37
    Path: /Services/Early Phase I to IIa

      2010-2019 59%
      ... Mineralocorticoid Receptor Antagonist Finerenone (BAY 94-8862) in Individuals with Mild or Moderate Hepatic Impairment. Eur J Drug Metab ... Mineralocorticoid Receptor Antagonist Finerenone (BAY 94-8862) in Individuals With Renal Impairment. Clin Pharmacol Drug Dev. 2016 Mar 31. doi: ... to assess changes in concentrations of biomarkers of exposure in
      Size: 70 K - Created: 09-11-15 - Modified: 19-03-20 19:04
    Path: /Expertise/Published Expertise/2010-2019

      1990 – 1999 48%
      ... Formulierung von Thyroxin und Iodid: Thyreocomb N. Therapiewoche 1996 ; 46(3). Timmer W, Kleist P, Ripke H. Lücker PW, Fuder H. Intra- and interindividual response to multiple dose treatment with four lansoprazole dosage regimen and a reference treatment with omeprazole. Poster, 6 th Annual ...
      Size: 61 K - Created: 18-11-12 - Modified: 02-08-19 10:27
    Path: /Expertise/Published Expertise/1990 – 1999

    Callback
    FooterEnd